Loading…
Targeting PTSD
In a sham-controlled study by N.S. Philip et al, the efficacy of intermittent theta-burst stimulation (iTBS) targeted at the right dorsolateral prefrontal cortex applied over a 10-day initial treatment period was assessed in veterans with posttraumatic stress disorder (PTSD). The study results suppo...
Saved in:
Published in: | The American journal of psychiatry 2019-11, Vol.176 (11), p.894-896 |
---|---|
Main Authors: | , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | In a sham-controlled study by N.S. Philip et al, the efficacy of intermittent theta-burst stimulation (iTBS) targeted at the right dorsolateral prefrontal cortex applied over a 10-day initial treatment period was assessed in veterans with posttraumatic stress disorder (PTSD). The study results support this innovative approach for the treatment of PTSD and demonstrate both the safety and efficacy of iTBS and the use of neuroimaging biomarkers to develop therapeutic treatment targets. Here, McDonald and van Rooij discuss the value of iTBS and places the findings from this study in the context of other TMS studies. They conclude that the study outlines the importance of emerging neuromodulation therapies and neuroimaging in providing personalized treatments and understanding the neurophysiology of psychiatric disorders. Neuroanatomic pathways can be mapped to determine the most appropriate stimulation sites. Subcortical targets that are particularly important in the neurophysiology of PTSD can be identified and targeted with iTBS, and Philip et al demonstrate the potential for targeted treatment in PTSD. |
---|---|
ISSN: | 0002-953X 1535-7228 |
DOI: | 10.1176/appi.ajp.2019.19080895 |